Brett R. Hagen
Known title: Chief Accounting OfficerCIK: 0001681782
Associated companies
Transaction History
| KLRS | ▼ Sell | Open Market | 1,915 | $13K | 3/20/2026 | View on chart |
| KLRS | ▼ Sell | Open Market | 907 | $8K | 3/26/2025 | View on chart |
| KLRS | ▼ Sell | Open Market | 96 | $967 | 2/21/2025 | View on chart |
| KLRS | ▼ Sell | Open Market | 32 | $303 | 1/23/2025 | View on chart |
| KLRS | ▼ Sell | Open Market | 4 | $40 | 1/23/2025 | View on chart |
| KLRS | ▼ Sell | Open Market | 332 | $146 | 1/10/2025 | View on chart |
| KLRS | ▼ Sell | Open Market | 554 | $304 | 11/19/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,655 | $1K | 11/5/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 486 | $373 | 10/22/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 479 | $373 | 10/21/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 301 | $245 | 10/3/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 544 | $413 | 8/19/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,692 | $1K | 8/5/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 481 | $356 | 7/22/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 479 | $359 | 7/19/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 304 | $219 | 7/2/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 541 | $405 | 5/17/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,597 | $1K | 5/3/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 480 | $360 | 4/22/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 473 | $355 | 4/19/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 281 | $217 | 4/2/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 494 | $343 | 2/20/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 11,150 | $7K | 2/8/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 5,792 | $4K | 2/5/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 901 | $604 | 1/23/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 310 | $198 | 1/4/2024 | View on chart |
| KLRS | ▼ Sell | Open Market | 28,335 | $21K | 12/27/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 403 | $657 | 11/17/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 357 | $550 | 10/20/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 358 | $566 | 10/19/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 222 | $439 | 10/3/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,653 | $4K | 8/17/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 342 | $1K | 7/20/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 342 | $1K | 7/19/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 5,045 | $28K | 6/9/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 349 | $1K | 4/20/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 348 | $1K | 4/19/2023 | View on chart |
| KLRS | ▲ Buy | Grant | 61,250 | $0 | 2/2/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 338 | $2K | 1/20/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,557 | $8K | 1/19/2023 | View on chart |
| KLRS | ▼ Sell | Open Market | 18,011 | $147K | 11/11/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 5,989 | $48K | 11/10/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 2,000 | $16K | 10/24/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 11,334 | $96K | 10/21/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 345 | $3K | 10/19/2022 | View on chart |
| KLRS | ▲ Buy | Grant | 20,000 | $0 | 8/16/2022 | View on chart |
| KLRS | ▲ Buy | Grant | 10,500 | $0 | 7/1/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 276 | $2K | 4/20/2022 | View on chart |
| KLRS | ▼ Sell | Open Market | 1,563 | $14K | 1/20/2022 | View on chart |
| KLRS | ▲ Buy | Grant | 17,442 | $0 | 1/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI
Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI. Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.